In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


4D Science GmbH

Latest From 4D Science GmbH

Private Equity Firm EQT Hopes Higher Cash Offer Will Win It Karo Pharma

Private equity firm EQT hopes a higher cash offer for Swedish specialty pharma group Karo Pharma than the one it made two months ago will persuade reluctant shareholders in the biotech to now sell their holdings.

M & A Commercial

Deals Shaping The Medical Industry, November 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced September through October 2013.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • 4D Science GmbH
  • Senior Management
  • Jorg Distler, MD, CEO
  • Contact Info
  • 4D Science GmbH
    Birkenallee 126
    Bubenrueth, 91088